The company
Celldex Therapeutics, Inc.
CLDX · Nasdaq
CLDX stood above a rising 150-day average in 44 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 14.0% below that average now. Diagnostics & Labs: 50% of its 44 stocks in an uptrend (+2 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 4
- Industry in uptrend
- 50% +2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $1.3M
- Officials’ trades on record
- 0
- Institutions holding
- 237 (+25)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 44 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 2026 | 9,543,671$355.1M | +983,195+11.5% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 7,002,530$260.6M | +1,632,645+30.4% |
| Kynam Capital Management, LPreduced · filed 14 Aug 2026 | 5,322,908$198.1M | -517,659−8.9% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,900,427$145.1M | +1,096,259+39.1% |
| FMR LLCreduced · filed 13 Aug 2026 | 3,722,888$138.5M | -26,160−0.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,464,831$128.9M | +503,936+17.0% |
| Deep Track Capital, LPadded · filed 14 Aug 2026 | 2,939,151$109.4M | +1,655,172+128.9% |
| Logos Global Management LPadded · filed 14 Aug 2026 | 2,100,000$78.1M | +1,650,000+366.7% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 2,022,226$75.3M | +334,152+19.8% |
| Eversept Partners, LPreduced · filed 14 Aug 2026 | 1,785,941$66.5M | -2,075−0.1% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.